查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1593038

静脉针市场：按规格、最终用户划分 - 2025-2030 年全球预测

Intravenous Needles Market by Gauges (18 Gauge, 20 Gauge, 22 Gauge), End User (Diagnostic Centers, Hospitals & Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年静脉注射针市场价值为20.3亿美元，预计2024年将达到21.4亿美元，复合年增长率为6.18%，到2030年将达到30.9亿美元。

静脉针市场范围包括设计用于将药物、营养物质和液体直接注射到患者静脉中的医疗设备，这在医院、门诊护理、家庭保健和紧急医疗服务等环境中非常重要。这种需求源自于有效药物输送的必要性，尤其是对于重症患者和慢性疾病患者。静脉针主要用于化疗、脱水治疗、输血、疼痛管理等。最终用户范围从医疗保健提供者到专科诊所和居家医疗，随着慢性病的流行和人口老化，需求不断增加。

主要市场统计
基准年[2023] 20.3亿美元
预测年份 [2024] 21.4亿美元
预测年份 [2030] 30.9亿美元
复合年增长率（%） 6.18%

主要成长动力包括安全设计针等技术进步、全球医疗保健支出增加以及发展中地区获得医疗保健的机会扩大。由于患者更喜欢在医院外接受治疗，家庭医疗保健市场的快速成长将进一步推动需求。医疗基础设施不断扩张的新兴市场存在机会。公司可以透过专注于产品安全、减少针刺伤害以及整合智慧技术来监控药品管理来利用技术创新。

由于严格的监管要求和高品质合规性的需要，也存在挑战。主要由于市场竞争动态和报销问题造成的定价压力可能会限製成长。此外，COVID-19 大流行扰乱了供应链并暂时影响了市场稳定。

创新领域包括开发具有增强安全机制的针头、开发减少医疗废弃物的环保材料以及追踪患者使用和管理效率的数位整合。与高科技公司建立伙伴关係来开发智慧针头解决方案可能会带来改变。此外，进行成本效益分析来证明先进针头溢价的合理性可以提高市场渗透率。为了在这竞争格局中获得优势，建议继续投资研发。儘管市场竞争仍然激烈，但随着重点转向以患者为中心的解决方案和居家照护创新，存在巨大的成长潜力。

市场动态：揭示快速发展的静脉针市场的关键市场洞察

供需的动态交互作用正在改变静脉注射针市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 医疗手术和程序数量的增加
    • 在严重监护环境中增加静脉注射针的使用
    • 家庭保健和自我用药的新趋势
  • 市场限制因素
    • 原材料成本波动和产品召回
  • 市场机会
    • 将静脉注射针相关产品融入远端医疗
    • 输液针製造的进展
  • 市场挑战
    • 担心针刺伤

波特五力：驾驭静脉针市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对静脉针市场的影响

外部宏观环境因素在塑造静脉针市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解静脉针市场的竞争状况

静脉针市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵静脉针市场供应商的绩效评估

FPNV定位矩阵是评估静脉针市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定静脉针市场成功之路的策略分析与建议

对于旨在加强其在全球市场的影响力的公司来说，对静脉针市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医疗手术和程序的增加
      • 加护病房中静脉注射针的使用增加
      • 家庭保健和自我用药的新趋势
    • 抑制因素
      • 原材料成本波动和产品召回
    • 机会
      • 输液针相关产品与远端医疗的整合
      • 静脉注射针製造的进步
    • 任务
      • 担心针刺伤
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 静脉针市场测算

  • 18号
  • 20号
  • 22号

第七章 静脉针市场：依最终使用者分类

  • 诊断中心
  • 医院/诊所

第八章美洲静脉针市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太静脉针市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲静脉针市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abcam Inc.
  • Advin Health Care
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomedical Srl
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Freudenberg Medical, LLC
  • Medtronic PLC
  • Merck KGaA
  • Novo Nordisk A/S
  • Olympus Corporation
  • PerkinElmer, Inc.
  • QIAGEN
  • Shimadzu Corporation
  • Siemens AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated.
  • Thermo Fisher Scientific Inc.
  • Volkmann MedizinTechnik GmbH
  • Zhejiang Longde Pharmaceutical Co., Ltd.
Product Code: MRR-F6513A06BEEA

The Intravenous Needles Market was valued at USD 2.03 billion in 2023, expected to reach USD 2.14 billion in 2024, and is projected to grow at a CAGR of 6.18%, to USD 3.09 billion by 2030.

The market scope for intravenous needles encompasses medical devices designed for infusing medications, nutrients, or fluids directly into patients' veins, critical in settings such as hospitals, ambulatory care, home healthcare, and emergency medical services. Their necessity is driven by the essential requirement for efficient drug delivery, especially in critical and chronic care scenarios. Intravenous needles are predominantly used in chemotherapy, dehydration treatment, blood transfusion, and pain management. The end-users range from healthcare providers to specialized clinics and home healthcare settings, where demand is tied to the rise in chronic disease prevalence and aging populations.

KEY MARKET STATISTICS
Base Year [2023] USD 2.03 billion
Estimated Year [2024] USD 2.14 billion
Forecast Year [2030] USD 3.09 billion
CAGR (%) 6.18%

Key growth-fostering factors include technological advancements like safety-engineered needles, increasing global healthcare expenditures, and expanded healthcare access in developing regions. The burgeoning home healthcare market further enhances demand, as patients prefer treatment outside hospital settings. Opportunities lie in emerging markets where healthcare infrastructure is expanding. Companies can leverage innovation by focusing on product safety, reducing needlestick injuries, and integrating smart technologies to monitor medication delivery.

Challenges persist due to stringent regulatory requirements and the need for high-quality compliance. Pricing pressures, primarily due to competitive market dynamics and reimbursement issues, may restrain growth. Moreover, the COVID-19 pandemic has disrupted supply chains, affecting market stability temporarily.

Innovation areas include developing needles with enhanced safety mechanisms, eco-friendly materials to reduce medical waste, and digital integration for tracking patient usage and dosage efficiency. Fostering partnerships with tech firms to develop smart needle solutions could be transformative. Additionally, conducting cost-benefit analyses to justify the premium pricing of advanced needles could aid market penetration. Continuous R&D investment is recommended to stay ahead in this competitive landscape. The market remains highly competitive with significant potential for growth as focus shifts towards patient-centric solutions and homecare innovations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Needles Market

The Intravenous Needles Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in number of medical surgeries and procedures
    • Growing use of IV needles in critical care settings
    • Emerging trend of home healthcare and self-administration of drugs
  • Market Restraints
    • Volatility in raw material cost and incidences of product recall
  • Market Opportunities
    • Integration of IV needle-related products with telemedicine
    • Advancements in IV needle manufacturing
  • Market Challenges
    • Concerns associated with needlestick injuries

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Needles Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Needles Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Needles Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Needles Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Needles Market

A detailed market share analysis in the Intravenous Needles Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Needles Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Needles Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Needles Market

A strategic analysis of the Intravenous Needles Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Needles Market, highlighting leading vendors and their innovative profiles. These include Abcam Inc., Advin Health Care, Argon Medical Devices, Inc., B. Braun SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomedical Srl, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Freudenberg Medical, LLC, Medtronic PLC, Merck KGaA, Novo Nordisk A/S, Olympus Corporation, PerkinElmer, Inc., QIAGEN, Shimadzu Corporation, Siemens AG, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated., Thermo Fisher Scientific Inc., Volkmann MedizinTechnik GmbH, and Zhejiang Longde Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Needles Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Gauges, market is studied across 18 Gauge, 20 Gauge, and 22 Gauge.
  • Based on End User, market is studied across Diagnostic Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in number of medical surgeries and procedures
      • 5.1.1.2. Growing use of IV needles in critical care settings
      • 5.1.1.3. Emerging trend of home healthcare and self-administration of drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Volatility in raw material cost and incidences of product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of IV needle-related products with telemedicine
      • 5.1.3.2. Advancements in IV needle manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with needlestick injuries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intravenous Needles Market, by Gauges

  • 6.1. Introduction
  • 6.2. 18 Gauge
  • 6.3. 20 Gauge
  • 6.4. 22 Gauge

7. Intravenous Needles Market, by End User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals & Clinics

8. Americas Intravenous Needles Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Intravenous Needles Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Needles Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam Inc.
  • 2. Advin Health Care
  • 3. Argon Medical Devices, Inc.
  • 4. B. Braun SE
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Biomedical Srl
  • 8. Boston Scientific Corporation
  • 9. Cardinal Health, Inc.
  • 10. Cook Group Incorporated
  • 11. Freudenberg Medical, LLC
  • 12. Medtronic PLC
  • 13. Merck KGaA
  • 14. Novo Nordisk A/S
  • 15. Olympus Corporation
  • 16. PerkinElmer, Inc.
  • 17. QIAGEN
  • 18. Shimadzu Corporation
  • 19. Siemens AG
  • 20. Smith & Nephew PLC
  • 21. Stryker Corporation
  • 22. Teleflex Incorporated.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Volkmann MedizinTechnik GmbH
  • 25. Zhejiang Longde Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. INTRAVENOUS NEEDLES MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAVENOUS NEEDLES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INTRAVENOUS NEEDLES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INTRAVENOUS NEEDLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAVENOUS NEEDLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAVENOUS NEEDLES MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 18 GAUGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 20 GAUGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 22 GAUGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. INTRAVENOUS NEEDLES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. INTRAVENOUS NEEDLES MARKET, FPNV POSITIONING MATRIX, 2023